| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.1840130415 |
| P698 | PubMed publication ID | 2010165 |
| P2093 | author name string | Williams R | |
| Johnson PJ | |||
| Donaldson PT | |||
| Doherty DG | |||
| Hayllar KM | |||
| McFarlane IG | |||
| P2860 | cites work | HLA‐Cw7 and HBS Ag negative chronic active hepatitis | Q71091829 |
| HLA types in liver disease in the West of Ireland | Q71185369 | ||
| Association of autoimmune active chronic hepatitis with HL-A1,8. | Q34202251 | ||
| HLA in different forms of chronic active hepatitis. A comparison between adult patients and children | Q34379704 | ||
| Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis | Q34529599 | ||
| Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis | Q36352181 | ||
| Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer | Q36355809 | ||
| HLA Determinants in Chronic Active Liver Disease: Possible Relation of HLA-Dw3 to Prognosis | Q39430301 | ||
| Increased Frequency of HLA-DRW4 in Chronic Active Hepatitis | Q39536413 | ||
| HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease | Q40920938 | ||
| Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. | Q43835473 | ||
| HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus | Q46138865 | ||
| Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. | Q54044273 | ||
| HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. | Q55060753 | ||
| Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. | Q64950937 | ||
| HLA and chronic active hepatitis | Q67576061 | ||
| Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes | Q68811038 | ||
| HLA typing and autoantibodies in hepatitis B surface antigen-negative chronic active hepatitis | Q68813285 | ||
| T-lymphocyte sensitization to hepatocyte antigens in autoimmune chronic active hepatitis and primary biliary cirrhosis. Evidence for different underlying mechanisms and different antigenic determinants as targets | Q68971030 | ||
| Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders | Q69695373 | ||
| HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis | Q69980447 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 701-706 | |
| P577 | publication date | 1991-04-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors | |
| P478 | volume | 13 |
| Q41660660 | "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis |
| Q39818050 | A 50-year experience with autoimmune hepatitis: and where are we now? |
| Q79671071 | A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1 |
| Q58143695 | Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis |
| Q40373033 | An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis |
| Q79738724 | Analysis of CD28 and bcl-2 expression on peripheral blood and liver-infiltrating mononuclear cells in patients with autoimmune hepatitis |
| Q47944773 | Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association |
| Q57062009 | Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease |
| Q98465718 | Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases |
| Q73671708 | Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis |
| Q43186281 | Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis |
| Q37068979 | Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians |
| Q26746242 | Auto immune hepatitis |
| Q54939025 | Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? |
| Q90093431 | Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination |
| Q72879582 | Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report |
| Q33870268 | Autoimmune hepatitis |
| Q71137776 | Autoimmune hepatitis |
| Q73831341 | Autoimmune hepatitis |
| Q73922527 | Autoimmune hepatitis |
| Q34371115 | Autoimmune hepatitis and its variant syndromes |
| Q35934744 | Autoimmune hepatitis and sclerosing cholangitis |
| Q26991971 | Autoimmune hepatitis in childhood: the role of genetic and immune factors |
| Q34936578 | Autoimmune hepatitis in children |
| Q80054493 | Autoimmune hepatitis in children |
| Q38103631 | Autoimmune hepatitis in diverse ethnic populations and geographical regions |
| Q45762603 | Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. |
| Q42985293 | Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance |
| Q36574524 | Autoimmune hepatitis--approach to diagnosis. |
| Q40590020 | Autoimmune hepatitis. Evolving concepts and treatment strategies |
| Q37346054 | Autoimmune hepatitis. Part A: pathogenesis |
| Q37346057 | Autoimmune hepatitis. Part B: diagnosis |
| Q48705433 | Autoimmune hepatitis: "Hepatitis sui generis". |
| Q34936564 | Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features |
| Q77721792 | Autoimmune liver disease |
| Q37182955 | Autoimmune paediatric liver disease |
| Q77798402 | Autoimmune polyglandular syndromes |
| Q72039839 | Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis |
| Q56904788 | CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis |
| Q34598372 | Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin |
| Q37948679 | Characteristics of autoimmune hepatitis in the Asia-Pacific Region: historical review |
| Q35960462 | Chronic hepatitis in Doberman pinschers. A review |
| Q28070154 | Cirrhosis and autoimmune liver disease: Current understanding |
| Q44100194 | Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. |
| Q37106402 | Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly |
| Q42996774 | Clinical impact of HLA DR B1 genotypes in chronic hepatitis C virus infection |
| Q73156189 | Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis |
| Q90285504 | Clinical, serological, histopathological and treatment profile of autoimmune hepatitis in the elderly |
| Q34875283 | Coeliac disease and liver dysfunction |
| Q36376398 | Cost-effectiveness of pharmacotherapy for autoimmune hepatitis |
| Q37885803 | Cryptogenic chronic hepatitis and its changing guise in adults |
| Q34490185 | Current and novel immunosuppressive therapy for autoimmune hepatitis |
| Q41199724 | Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens |
| Q78176997 | Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis |
| Q56906375 | Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis |
| Q34369562 | DLA class II alleles and haplotypes are associated with risk for and protection from chronic hepatitis in the English Springer spaniel |
| Q74242368 | De-novo autoimmune hepatitis after liver transplantation |
| Q48758554 | Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis |
| Q38007886 | Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation |
| Q39290190 | Diagnostic approach to autoimmune hepatitis |
| Q82640069 | Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly |
| Q78023538 | Drug therapy in the management of type 1 autoimmune hepatitis |
| Q37843783 | Drug-induced autoimmune-like hepatitis |
| Q35816428 | Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis |
| Q43048900 | Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States |
| Q36462775 | Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis. |
| Q39677764 | Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury |
| Q33875117 | Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis |
| Q44553038 | Frequency and significance of antibodies to chromatin in autoimmune hepatitis |
| Q54405950 | Genetic background of autoimmune hepatitis in Japan. |
| Q34978479 | Genetic bases of autoimmune hepatitis. |
| Q34406835 | Genetic distinctions between autoimmune hepatitis in Italy and North America |
| Q34936668 | Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis |
| Q38667675 | Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis |
| Q71598504 | Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis |
| Q70496840 | Genetic predispositions for the immunological features of chronic active hepatitis |
| Q39436336 | Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis |
| Q80352996 | HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients |
| Q72003445 | HLA antigens in patients with chronic hepatitis C |
| Q41544167 | HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. |
| Q43479532 | Hepatitis C virus and autoimmunity: Fortuitous association or reality? |
| Q37182927 | Historical reflections on autoimmune hepatitis |
| Q37257526 | Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis |
| Q45773308 | Immunogenetic background of hepatitis B virus infection and autoimmune hepatitis in Japan. |
| Q41199734 | Immunogenetics in liver disease |
| Q70694090 | Immunogenetics of autoimmune chronic active hepatitis |
| Q27473546 | Immunological abnormalities and hepatotropic viral infections |
| Q28069584 | Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? |
| Q47409507 | Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant |
| Q77344193 | Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis |
| Q64928504 | Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis. |
| Q44258227 | Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus |
| Q50897195 | Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? |
| Q52877430 | Limited usage of T-Cell receptor β chains and sequences of the complementarity determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis |
| Q27478345 | Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis |
| Q44455344 | Long-term outcome of Japanese patients with type 1 autoimmune hepatitis |
| Q28248437 | MHC class II genes influence the susceptibility to chronic active hepatitis C |
| Q47809505 | MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis |
| Q45254403 | MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury |
| Q34170467 | Mechanisms of autoimmune liver disease |
| Q34559789 | Mechanisms of liver injury relevant to pediatric hepatology |
| Q35016702 | Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model |
| Q70496892 | Meeting report: International Autoimmune Hepatitis Group |
| Q35126088 | Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis |
| Q92846251 | Novel HLA Class I Alleles Outside the Extended DR3 Haplotype Are Protective against Autoimmune Hepatitis |
| Q37346015 | Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases |
| Q33698264 | Pathogenesis of autoimmune hepatitis |
| Q78322634 | Pathogenesis of autoimmune hepatitis |
| Q59354446 | Pathogens and autoimmune hepatitis |
| Q38318118 | Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition |
| Q53147279 | Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients. |
| Q58143700 | Polymorphism in the Human Complement C4 Genes and Genetic Susceptibility to Autoimmune Hepatitis |
| Q41583334 | Prediction of short- and long-term outcome in patients with autoimmune hepatitis |
| Q34140818 | Primary biliary cirrhosis with features of autoimmune hepatitis |
| Q67743320 | Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis |
| Q44927729 | Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis |
| Q56740898 | RETRACTED: Significant association of HLA-DQ5 with autoimmune hepatitis in Taiwan |
| Q44078600 | Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans |
| Q40044046 | Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis |
| Q26827599 | Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis |
| Q78177021 | Searching for the needle in the haystack: another candidate needle in autoimmune hepatitis? |
| Q44225005 | Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare |
| Q57062596 | Sex-related factors in autoimmune liver diseases |
| Q71811705 | Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis |
| Q33370043 | Successful treatment with cyclosporine A of HCV-driven chronic liver disease mimicking autoimmune hepatitis in a patient with common variable immunodeficiency |
| Q34245122 | Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype |
| Q73419921 | T cell receptor Vbeta chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients |
| Q87317541 | The early onset of type 1 autoimmune hepatitis has a strong genetic influence: role of HLA and KIR genes |
| Q34664271 | The impact of ethnicity on the natural history of autoimmune hepatitis |
| Q49036478 | The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. |
| Q38025405 | The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome |
| Q35350742 | The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis |
| Q34149523 | Treatment of autoimmune hepatitis: A review of current and evolving therapies |
| Q51779484 | Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. |
| Q33868482 | Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis |
| Q34936633 | Variant syndromes of autoimmune hepatitis |
Search more.